… TB, we found that the absorbance value of IGRA-ELISA and the number of SFCs of T-SPOT.TB
in tuberculosis patients were significantly higher than those in other lung diseases (p < …

… in performance of the two assays for the diagnosis of M. tuberculosis infection and active TB
disease. As the T-SPOT.TB test and IGRA-ELISA are both used in our hospital, in this study, …

… we reviewed the literature regarding the tests available for TB infection diagnosis, the
preventive therapies options and the cascade of care for controlling TB at a public health level. …

… -specific immune responses is widely used for detecting infection in the absence of TB
symptoms (ie latent TB infection), there is currently no role for immunodiagnostics in active …

… ABSTRACT We compared the usefulness of three methods designed to diagnose latent
tuberculosis [TB]: interferongamma release assay [IGRA], such as QuantiFERON-…

… vitro diagnostic tests (IGRAs) for TB infection, such as QFT and T-SPOT.TB, and the future
landscape of the diagnosis of TB … Therefore, AdvanSure TB-IGRA ELISA was omitted from this …

… diagnosing stages of TB from TB infection to TB disease. This review gives an overview of
recent progress in host- and pathogen-based TB … guidelines on TB screening and diagnosis. …

… AdvanSure TB-IGRA ELISA uses a peptide form of ESAT-6 and CFP-10 antigens. The test
is … Promising new tests may bring diagnosis for TB infection and prognosis of TB disease …

… may be inconsistent due to risk of false-negative results and active TB may not translate to
accurate diagnosis of latent TB. Longitudinal studies requiring long-term follow-up of large …

… Eligible studies assessed sensitivity in patients with newly diagnosed active TB, and … with
intermediate TB incidence rates (10–120 cases per 100000/year), as well as low TB incidence …